SEP 13, 2017 10:00 AM PDT

WEBINAR: Microbiology's role in Sepsis Core Measures

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • System Director, Clinical and Molecular Biology at Geisinger Diagnostic Medicine Institute
      Dr. Donna Wolk is the System Director for Clinical and Molecular Microbiology at Geisinger Health System, an integrated delivery system in Pennsylvania. As a Diplomate of the American Board of Medical Microbiology (ABMM), Dr. Wolk's professional practice extends to the national and international level, supporting initiatives in clinical and molecular microbiology and laboratory leadership. Active in the American Society of Microbiology, among others, she is most well known for her strategic thinking and predications about new technology and its impact to patient care, as well as her work as one of seven founding members of CDC/ASM collaboration for Evidence Based Laboratory Medicine Best Practices. Dr. Wolk was selected as a Clinical Research Scholar at the University of Arizona and in 2012, she received the 1885 Distinguished Scholar Award, which acknowledges outstanding faculty whose research, scholarship, and creative contributions exemplify innovation, service, and success in their respective disciplines. She is the 2016 award laureate, selected by the American Society for Microbiology to receive the BD Award for Clinical Research in Microbiology.


    DATE: September 13, 2017
    TIME: 10:00am PT, 1:00pm ET


    As part of BD’s commitment to increased awareness to the health and financial burden associated with Sepsis, BD is sponsoring an educational webinar in recognition of  World Sepsis Day. This global disease, impacting an estimated 31 Million people world wide with an estimated 5 million deaths annually, is preventable and treatable through increased awareness and education.

    This session will frame the importance of blood cultures as they relate to the Surviving Sepsis Campaign and to healthcare’s efforts to reduce mortality from sepsis. It will also provide tips for laboratorians who seek to better characterize and report their quality metrics and associated improvement in their metrics to provide evidence of the laboratory contribution to sepsis programs.

    Learning Objectives:

    • Introduce the concepts of core measures for sepsis and their impact on hospitals.
    • Review ways that Microbiology laboratories can support efforts to improve core measures and sepsis outcomes.
    • Give examples of blood culture metrics and how they can support their organization’s sepsis program.
    • Review simple statistics that support laboratory quality initiatives for blood culture processes.



    Show Resources
    Loading Comments...